U.S. markets open in 2 hours 49 minutes

Avalo Therapeutics, Inc. (AVTX)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
2.4600+0.0700 (+2.93%)
At close: 4:00PM EDT
2.5300 +0.07 (2.85%)
Pre-Market: 06:17AM EDT
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Commodity Channel Index

Commodity Channel Index

Previous Close2.3900
Open2.4100
Bid0.0000 x 4000
Ask2.5900 x 2200
Day's Range2.3700 - 2.4700
52 Week Range1.9800 - 4.5000
Volume365,996
Avg. Volume622,607
Market Cap276.302M
Beta (5Y Monthly)1.46
PE Ratio (TTM)N/A
EPS (TTM)-0.8670
Earnings DateNov 08, 2021 - Nov 12, 2021
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est6.50
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • Avalo Therapeutics, Inc.
    SUPN: What does Argus have to say about SUPN?SUPERNUS PHARMACEUTICALS INC has an Investment Rating of HOLD; a target price of $29.000000; an Industry Subrating of High; a Management Subrating of Medium; a Safety Subrating of Medium; a Financial Strength Subrating of Low; a Growth Subrating of Medium; and a Value Subrating of Low.
    Rating
    Fair Value
    Economic Moat
    2 days agoArgus Research
View more